Science-Backed Weight Loss with GLP-1 Medications
GLP-1 and GIP analogs such as Saxenda, Ozempic, and Mounjaro.
¡Live without limits!
Real Results Simulator
Adjust your data and visualize your transformation
Pathologies and Accumulated Risks:
SAXENDA
Daily Injection
- Active: Liraglutide 3 mg
- Daily appetite control
- Ideal for moderate weight loss
OZEMPIC / WEGOVY
Weekly Injection
- Active: Semaglutide
- Only one dose per week
- High metabolic efficacy
MOUNJARO
Weekly Dual Injection
- Tirzepatide (GLP-1 + GIP)
- Maximum potency available
- Surgical-level results
What are GLP-1 analogues and how do they work?
GLP-1 analogues mimic the GLP-1 intestinal hormone, which is released after eating to signal fullness and satiety to the brain.
Reduce Appetite
They increase the feeling of satiety, helping you feel satisfied with smaller portions of food.
Slow Down Digestion
By slowing gastric emptying, they help you eat less without feeling constant hunger.
Improve Metabolism
They enhance insulin production and action, providing superior glucose control.
What are GIP analogues and how do they work in your body?
GIP (Glucose-dependent Insulinotropic Polypeptide) analogues are molecules designed to mimic the function of natural hormones in our gut (incretins). Unlike other treatments, these optimize the metabolic response only when the body needs it, achieving superior hormonal balance.
Primary Mechanisms of Action:
"This technology represents the most significant breakthrough in metabolic medicine of the last decade."
Why is the combination of GIP and GLP-1 important?
The interaction between GIP and GLP-1 allows for a comprehensive approach to metabolic control, working complementarily on four fundamental pillars:
SAXENDA
First GLP-1 approved for obesityKey Features:
- Active ingredient: Liraglutide up to 3 mg daily
- Administration: Daily subcutaneous injection (pen)
- Indication: BMI ≥ 30, or ≥ 27 with comorbidities
SCALE Study: average over 56 weeks.
A 100 kg person can lose approx. 8 kg in one year.
OZEMPIC / WEGOVY (Semaglutide)
Weekly Injection • Revolutionary in weight loss
Key difference:
Ozempic: Approved for type 2 diabetes (up to 1 mg).
Wegovy: Specifically approved for obesity (up to 2.4 mg).
Main Features:
- Administration: One weekly subcutaneous injection
- Convenience: Same day each week
- Experience: Less hunger and increased satiety
STEP-1 Study: average loss in 68 weeks.
A 100 kg person can lose approx. 15 kg in 16 months.
MOUNJARO / ZEPBOUND (Tirzepatide)
Weekly Injection • Dual GLP-1 + GIP Action • 2026 VanguardExclusive Innovation: Tirzepatide is a dual GLP-1 and GIP receptor agonist, activating two incretin hormones instead of just one. This produces a more potent effect on fat metabolism and weight loss.
Advantages of Dual Mechanism:
- Superior glucose control
- Intense effect on fat metabolism
- Marked appetite reduction
- Superior weight loss vs conventional GLP-1s
SURMOUNT-1 Study: Up to 22.5% loss over 72 weeks.
A 100 kg person can lose 20-22 kg or more.
What does this mean for you?
These effects translate into lower caloric intake, reduced food cravings, and weight loss when combined with diet and exercise.
They are used for both type 2 diabetes and obesity; some were first approved for diabetes and later (at higher doses) for obesity management.
Semaglutide
Ozempic: Lower doses for diabetes
Wegovy: Higher doses for obesity
Liraglutide
Victoza: 1.8 mg for diabetes
Saxenda: 3 mg for weight loss
Tirzepatide
Mounjaro: Glycemic control (Diabetes)
Zepbound: Weight management (Obesity)
Important Safety Information
These medications are not for everyone. You should NOT use these treatments if you have:
Medical Supervision
For safe and effective results, we ensure the following clinical standards:
Key Benefits of GLP-1 Agonists for Weight Loss
Real, sustained, and clinically proven weight reduction
Significant Weight Loss
Expect a reduction from 5-10% up to over 20% of total body weight, depending on the specific medication.
Improved Glycemic Control
Essential for prediabetes or diabetes, effectively stabilizing blood sugar and HbA1c levels.
Cardiovascular Protection
Proven reduction in blood pressure with significant long-term heart and kidney health benefits.
Reduced Food Cravings
Easier portion control and habit maintenance without the burden of constant hunger.
Convenient Dosing
Simple weekly administration for the majority of modern pharmacological treatments.
Superior Outcomes
Enhanced efficacy that outperforms traditional weight loss methods through biological regulation.
Why choose GLP-1 medication?
Safety and results powered by modern metabolic science.
This is medication for exclusive medical use
You are not alone in this journey. For treatment to be safe and truly effective, the support of a multidisciplinary team is essential to back you up at every stage.
Nutrition
You will learn to eat mindfully and nutritiously, enjoying food without guilt or extreme restrictions.
Psychology
We will address your relationship with food and emotional management to achieve sustainable change.
Sports Medicine
We will help you move safely, respecting your body's limits while boosting your metabolism.
Who is this treatment for?
This medical treatment is designed for patients seeking an effective and professionally supervised solution.
Ideal Patient Profile
- Adults with obesity (BMI ≥ 30)
- Overweight with related health conditions (BMI ≥ 27)
- Patients who haven't achieved results with diet alone
- Individuals with high appetite or insulin resistance
Associated Comorbidities
- Type 2 Diabetes or Prediabetes
- Hypertension (High Blood Pressure)
- Obstructive Sleep Apnea
- Fatty Liver Disease (NAFLD)
- Dyslipidemia (High Cholesterol)
Medical Assessment Required
A prior medical assessment is required to determine if you are a candidate for GLP-1 analogue treatment. Our team will evaluate your medical history, BMI, and lab tests.
Find out if you are a candidate. Book your assessmentPreclinical and Clinical Obesity
BMI remains an important tool, but it is no longer the sole criterion for defining obesity or initiating treatment.
According to updated criteria from The Lancet (2025), conditions associated with excess body fat tissue are key factors in identifying preclinical and clinical obesity. These indicators determine the need for medical treatment, even in early stages.
These conditions reflect a real impact of adipose tissue on overall health, allowing for timely intervention that goes beyond just the number on the scale.
Additional Indications for Medical Treatment
- Patients experiencing weight regain after bariatric surgery.
- Patients with insufficient weight loss following bariatric surgery.
- Patients with a swallowable gastric balloon wishing to enhance results.
- Patients with medical contraindications for surgical intervention.
Medications originally developed for Type 2 Diabetes that are now utilized for obesity management, achieving weight loss results previously only possible through bariatric surgery.
"It's not magic; it's modern medicine backed by science."Safety, Side Effects, and Responsible Use
GLP-1 agonists are generally safe and well-tolerated when medically supervised.
Most Common Side Effects
Management Strategies
Rare but Important Adverse Effects
Treatment Duration
This is a medium to long-term treatment: minimum 6-12 months, ideally 1-2 years for optimal and sustainable results.
Important: Discontinuing treatment prematurely may lead to weight regain. Improving dietary habits and physical activity during the process is vital.
Treatment Process – Step by Step
How our comprehensive weight loss program works
Comprehensive Medical Assessment
Full medical history, BMI evaluation, and laboratory tests (glucose, lipid profile, liver, kidney, and thyroid function).
Medication Selection
Selection of Saxenda, Ozempic/Wegovy, or Mounjaro based on your clinical profile, budget, and specific goals.
In-depth Treatment Overview
Detailed explanation of mechanism of action, dosages, expected outcomes, and side effect management.
Hands-on Training
Practical guidance on using the injectable pen: dose preparation, technique, and proper storage.
Nutritional & Activity Support
Personalized lifestyle recommendations. The medication is significantly more effective when paired with healthy habits.
Regular Progress Checks
Ongoing follow-up to adjust dosages, monitor lab work, and maintain long-term motivation.
"GLP-1 agonists offer results previously only achievable through bariatric surgery, but in a non-invasive way."
Frequently Asked Questions
Addressing your concerns about GLP-1 analogue treatments
Ozempic/Wegovy: Weekly administration, 10-15% weight loss.
Mounjaro/Zepbound: Most potent option (dual mechanism), weekly administration, 15-22% weight loss. The choice depends on your specific health goals.
Have more questions?
Our medical team is available to address any concerns during a personalized consultation.
Contact on WhatsAppGLP-1 analogues have changed the way obesity is treated
It's not just about losing weight; it's about reclaiming your health and quality of life.
With weight loss ranging from 8% to 22%, improved metabolic parameters, and a proven safety profile, GLP-1 agonists represent modern medicine applied to obesity management.
Book your medical assessment and discover which treatment is right for you
Responsible Medical Disclaimer: GLP-1 medications must be prescribed and supervised by healthcare professionals. They are not over-the-counter products or "magic pills." Medication is always integrated into a comprehensive plan that includes balanced nutrition, regular physical activity, and periodic medical follow-ups for sustainable results.
